Contact Us

HOTEL NEWS

KINN Habitat: Affordable Urban Wellness in the Heart of the City

Feb 10, 2025

KINN\'s Flagship Property showcases an upgraded version of their signature capsules,stylish private rooms,and an expansive event space for a truly elevated experience.

CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4

Feb 10, 2025

SHANGHAI,Feb. 10,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Billion Electric Group Delivers 100% Green Energy to Pacific Islands with Smart Solar-Storage Microgrids

Feb 10, 2025

KOROR,Palau,Feb. 9,2025--Billion Electric Group (TWSE: 3027),in collaboration with Taiwanese partners,has successfully deployed 495 kWp of solar PV and 1,997 kWh of battery energy storage systems (BES

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Feb 7, 2025

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

Feb 7, 2025

NEW YORK,Feb. 5,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insights

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Feb 7, 2025

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

1 ... 84 85 86 87 88 89 90 ... 343